Macrophages promote oxidative metabolism to drive nitric oxide generation in response to Trypanosoma cruzi

Sue Jie Koo, Imran H. Chowdhury, Bartosz Szczesny, Xianxiu Wan, Nisha Garg

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Trypanosoma cruzi is the causative agent of chronic chagasic cardiomyopathy. Why macrophages (mφs), the early responders to infection, fail to achieve parasite clearance is not known. Mouse (RAW 264.7) and human (THP-1 and primary) mφs were infected for 3 h and 18 h with T. cruzi TcI isolates, SylvioX10/4 (SYL, virulent) and TCC (nonpathogenic), which represent mφ stimulation and infection states, respectively. Mφs incubated with lipopolysaccharide and gamma interferon (LPS/IFN-γ) and with interleukin-4 (IL-4) were used as controls. We monitored the cytokine profile (using enzyme-linked immunosorbent assay [ELISA]), reactive oxygen species (ROS; fluorescent probes), nitric oxide (NO; Griess assay), and metabolic state using a customdesigned mitoxosome array and Seahorse XF24 Analyzer. LPS/IFN-γ treatment of mφs elicited a potent increase in production of tumor necrosis alpha (TNF-α) at 3 h and of ROS and NO by 18 h. Upon SYL infection, murine mφs elicited an inflammatory cytokine profile (TNF-α≫TGF-β+IL-10) and low levels of NO and ROS production. LPS/IFN-γ treatment resulted in the inhibition of oxidative metabolism at the gene expression and functional levels and a switch to the glycolytic pathway in mφs, while IL-4-treated mφs utilized oxidative metabolism to meet energy demands. SYL infection resulted in an intermediate functional metabolic state with increased mitoxosome gene expression and glycolysis, and IFN-γ addition shut down the oxidative metabolism in SYL-infected mφs. Further, TCC- and SYL-stimulated mφs exhibited similar levels of cell proliferation and production of TNF-α and ROS, while TCC-stimulated mφs exhibited up to 2-fold-higher levels of oxidative metabolism and NO production than SYL-infected mφs. Inhibiting ATP-coupled O2 consumption suppressed the NO generation in SYL-infected mφs. Mitochondrial oxygen consumption constitutes a mechanism for stimulating NO production in mφs during T. cruzi infection. Enhancing the oxidative metabolism provides an opportunity for increased NO production and pathogen clearance by mφs to limit disease progression.

Original languageEnglish (US)
Pages (from-to)3527-3541
Number of pages15
JournalInfection and Immunity
Volume84
Issue number12
DOIs
StatePublished - 2016

Fingerprint

Trypanosoma cruzi
Nitric Oxide
Macrophages
Interferon-gamma
Lipopolysaccharides
Infection
Interleukin-4
Cytokines
Smegmamorpha
Gene Expression
Glycolysis
Cardiomyopathies
Fluorescent Dyes
Oxygen Consumption
Interleukin-10
Disease Progression
Reactive Oxygen Species
Parasites
Necrosis
Adenosine Triphosphate

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases

Cite this

Macrophages promote oxidative metabolism to drive nitric oxide generation in response to Trypanosoma cruzi. / Koo, Sue Jie; Chowdhury, Imran H.; Szczesny, Bartosz; Wan, Xianxiu; Garg, Nisha.

In: Infection and Immunity, Vol. 84, No. 12, 2016, p. 3527-3541.

Research output: Contribution to journalArticle

@article{d643f4fcd24c431d9e381b2a3b5efec0,
title = "Macrophages promote oxidative metabolism to drive nitric oxide generation in response to Trypanosoma cruzi",
abstract = "Trypanosoma cruzi is the causative agent of chronic chagasic cardiomyopathy. Why macrophages (mφs), the early responders to infection, fail to achieve parasite clearance is not known. Mouse (RAW 264.7) and human (THP-1 and primary) mφs were infected for 3 h and 18 h with T. cruzi TcI isolates, SylvioX10/4 (SYL, virulent) and TCC (nonpathogenic), which represent mφ stimulation and infection states, respectively. Mφs incubated with lipopolysaccharide and gamma interferon (LPS/IFN-γ) and with interleukin-4 (IL-4) were used as controls. We monitored the cytokine profile (using enzyme-linked immunosorbent assay [ELISA]), reactive oxygen species (ROS; fluorescent probes), nitric oxide (NO; Griess assay), and metabolic state using a customdesigned mitoxosome array and Seahorse XF24 Analyzer. LPS/IFN-γ treatment of mφs elicited a potent increase in production of tumor necrosis alpha (TNF-α) at 3 h and of ROS and NO by 18 h. Upon SYL infection, murine mφs elicited an inflammatory cytokine profile (TNF-α≫TGF-β+IL-10) and low levels of NO and ROS production. LPS/IFN-γ treatment resulted in the inhibition of oxidative metabolism at the gene expression and functional levels and a switch to the glycolytic pathway in mφs, while IL-4-treated mφs utilized oxidative metabolism to meet energy demands. SYL infection resulted in an intermediate functional metabolic state with increased mitoxosome gene expression and glycolysis, and IFN-γ addition shut down the oxidative metabolism in SYL-infected mφs. Further, TCC- and SYL-stimulated mφs exhibited similar levels of cell proliferation and production of TNF-α and ROS, while TCC-stimulated mφs exhibited up to 2-fold-higher levels of oxidative metabolism and NO production than SYL-infected mφs. Inhibiting ATP-coupled O2 consumption suppressed the NO generation in SYL-infected mφs. Mitochondrial oxygen consumption constitutes a mechanism for stimulating NO production in mφs during T. cruzi infection. Enhancing the oxidative metabolism provides an opportunity for increased NO production and pathogen clearance by mφs to limit disease progression.",
author = "Koo, {Sue Jie} and Chowdhury, {Imran H.} and Bartosz Szczesny and Xianxiu Wan and Nisha Garg",
year = "2016",
doi = "10.1128/IAI.00809-16",
language = "English (US)",
volume = "84",
pages = "3527--3541",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Macrophages promote oxidative metabolism to drive nitric oxide generation in response to Trypanosoma cruzi

AU - Koo, Sue Jie

AU - Chowdhury, Imran H.

AU - Szczesny, Bartosz

AU - Wan, Xianxiu

AU - Garg, Nisha

PY - 2016

Y1 - 2016

N2 - Trypanosoma cruzi is the causative agent of chronic chagasic cardiomyopathy. Why macrophages (mφs), the early responders to infection, fail to achieve parasite clearance is not known. Mouse (RAW 264.7) and human (THP-1 and primary) mφs were infected for 3 h and 18 h with T. cruzi TcI isolates, SylvioX10/4 (SYL, virulent) and TCC (nonpathogenic), which represent mφ stimulation and infection states, respectively. Mφs incubated with lipopolysaccharide and gamma interferon (LPS/IFN-γ) and with interleukin-4 (IL-4) were used as controls. We monitored the cytokine profile (using enzyme-linked immunosorbent assay [ELISA]), reactive oxygen species (ROS; fluorescent probes), nitric oxide (NO; Griess assay), and metabolic state using a customdesigned mitoxosome array and Seahorse XF24 Analyzer. LPS/IFN-γ treatment of mφs elicited a potent increase in production of tumor necrosis alpha (TNF-α) at 3 h and of ROS and NO by 18 h. Upon SYL infection, murine mφs elicited an inflammatory cytokine profile (TNF-α≫TGF-β+IL-10) and low levels of NO and ROS production. LPS/IFN-γ treatment resulted in the inhibition of oxidative metabolism at the gene expression and functional levels and a switch to the glycolytic pathway in mφs, while IL-4-treated mφs utilized oxidative metabolism to meet energy demands. SYL infection resulted in an intermediate functional metabolic state with increased mitoxosome gene expression and glycolysis, and IFN-γ addition shut down the oxidative metabolism in SYL-infected mφs. Further, TCC- and SYL-stimulated mφs exhibited similar levels of cell proliferation and production of TNF-α and ROS, while TCC-stimulated mφs exhibited up to 2-fold-higher levels of oxidative metabolism and NO production than SYL-infected mφs. Inhibiting ATP-coupled O2 consumption suppressed the NO generation in SYL-infected mφs. Mitochondrial oxygen consumption constitutes a mechanism for stimulating NO production in mφs during T. cruzi infection. Enhancing the oxidative metabolism provides an opportunity for increased NO production and pathogen clearance by mφs to limit disease progression.

AB - Trypanosoma cruzi is the causative agent of chronic chagasic cardiomyopathy. Why macrophages (mφs), the early responders to infection, fail to achieve parasite clearance is not known. Mouse (RAW 264.7) and human (THP-1 and primary) mφs were infected for 3 h and 18 h with T. cruzi TcI isolates, SylvioX10/4 (SYL, virulent) and TCC (nonpathogenic), which represent mφ stimulation and infection states, respectively. Mφs incubated with lipopolysaccharide and gamma interferon (LPS/IFN-γ) and with interleukin-4 (IL-4) were used as controls. We monitored the cytokine profile (using enzyme-linked immunosorbent assay [ELISA]), reactive oxygen species (ROS; fluorescent probes), nitric oxide (NO; Griess assay), and metabolic state using a customdesigned mitoxosome array and Seahorse XF24 Analyzer. LPS/IFN-γ treatment of mφs elicited a potent increase in production of tumor necrosis alpha (TNF-α) at 3 h and of ROS and NO by 18 h. Upon SYL infection, murine mφs elicited an inflammatory cytokine profile (TNF-α≫TGF-β+IL-10) and low levels of NO and ROS production. LPS/IFN-γ treatment resulted in the inhibition of oxidative metabolism at the gene expression and functional levels and a switch to the glycolytic pathway in mφs, while IL-4-treated mφs utilized oxidative metabolism to meet energy demands. SYL infection resulted in an intermediate functional metabolic state with increased mitoxosome gene expression and glycolysis, and IFN-γ addition shut down the oxidative metabolism in SYL-infected mφs. Further, TCC- and SYL-stimulated mφs exhibited similar levels of cell proliferation and production of TNF-α and ROS, while TCC-stimulated mφs exhibited up to 2-fold-higher levels of oxidative metabolism and NO production than SYL-infected mφs. Inhibiting ATP-coupled O2 consumption suppressed the NO generation in SYL-infected mφs. Mitochondrial oxygen consumption constitutes a mechanism for stimulating NO production in mφs during T. cruzi infection. Enhancing the oxidative metabolism provides an opportunity for increased NO production and pathogen clearance by mφs to limit disease progression.

UR - http://www.scopus.com/inward/record.url?scp=85002581865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002581865&partnerID=8YFLogxK

U2 - 10.1128/IAI.00809-16

DO - 10.1128/IAI.00809-16

M3 - Article

VL - 84

SP - 3527

EP - 3541

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 12

ER -